National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
Contains
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

dacarbazine  Patient Information
A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms:Biocarbazine
Dacarbazina
Dacarbazina Almirall
Dacarbazine - DTIC
Dakarbazin
Dimethyl (triazeno) imidazolecarboxamide
Dimethyl Triazeno Imidazol Carboxamide
Dimethyl Triazeno Imidazole Carboxamide
Imidazole Carboxamide
Imidazole Carboxamide Dimethyltriazeno
US brand name:DTIC-Dome
Foreign brand names:Asercit
Dacatic
Deticene
Detimedac
Fauldetic
Abbreviations:DIC
DTIC
Code name:WR-139007
Chemical structure names:
  • 1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-
  • 5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide
  • 5-(dimethyltriazeno)imidazole-4-carboxamide
  • 5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov